康臣药业(01681.HK)10月22日耗资433.1万港元回购28.3万股
Core Viewpoint - 康臣药业 announced a share buyback of 283,000 shares at a cost of HKD 4.331 million on October 22 [1] Company Summary - 康臣药业 executed a buyback program, indicating a commitment to returning value to shareholders [1] - The total expenditure for the buyback was HKD 4.331 million, reflecting the company's strategy to manage its capital structure [1] - The number of shares repurchased was 283,000, which may influence the company's stock performance and market perception [1]